• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨科患者静脉血栓栓塞的风险:流行病学和生理学数据。

The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data.

作者信息

Paiement G D, Mendelsohn C

机构信息

University of California at San Francisco, USA.

出版信息

Orthopedics. 1997 Feb;20 Suppl:7-9.

PMID:9048400
Abstract

Venous thromboembolism is responsible for 500,000 deaths annually in industrialized countries. It is probably the most common preventable cause of death in elective orthopedic surgery patients. Rates of deep vein thrombosis (DVT) and fatal pulmonary embolism (PE) in unprotected orthopedic patient populations are high. The overall DVT rate is > 40% in patients undergoing hip or knee arthroplasty or suffering from multiple injuries. The proximal DVT rate for these patients is > or = 15%, and the fatal PE rate is > or = 1%. Risk factors associated with venous thromboembolism are related to the vascular injury, activation of blood coagulation, and venous stasis. Lower extremity orthopedic procedures carry a risk greater than that of surgery itself. Thus, orthopedic patients are at high risk for venous thromboembolic conditions. A systematic assessment of this risk should be performed in every patient, and an appropriate management plan should be implemented.

摘要

在工业化国家,静脉血栓栓塞每年导致50万人死亡。它可能是择期骨科手术患者中最常见的可预防死亡原因。在未采取预防措施的骨科患者群体中,深静脉血栓形成(DVT)和致命性肺栓塞(PE)的发生率很高。接受髋关节或膝关节置换术或多处受伤的患者中,总体DVT发生率>40%。这些患者的近端DVT发生率>或=15%,致命性PE发生率>或=1%。与静脉血栓栓塞相关的危险因素与血管损伤、凝血激活和静脉淤滞有关。下肢骨科手术的风险大于手术本身。因此,骨科患者发生静脉血栓栓塞性疾病的风险很高。应对每位患者进行这种风险的系统评估,并实施适当的管理计划。

相似文献

1
The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data.骨科患者静脉血栓栓塞的风险:流行病学和生理学数据。
Orthopedics. 1997 Feb;20 Suppl:7-9.
2
The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data.
Orthopedics. 1997 Feb;20:7-9. doi: 10.3928/0147-7447-19970202-05.
3
The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.全膝关节置换术中血栓形成倾向和静脉血栓栓塞的患病率。
J Med Assoc Thai. 2007 Jul;90(7):1342-7.
4
[Epidemiology and etiopathogenesis of deep venous thrombosis of the lower limbs].[下肢深静脉血栓形成的流行病学与发病机制]
Agressologie. 1990 Mar;31(3):141-3.
5
Thromboembolic complications after spinal surgery in trauma patients.创伤患者脊柱手术后的血栓栓塞并发症。
Acta Orthop. 2006 Oct;77(5):755-60. doi: 10.1080/17453670610012944.
6
Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.希美加群用于预防择期髋关节或膝关节置换术后静脉血栓栓塞。
Semin Vasc Med. 2005 Aug;5(3):266-75. doi: 10.1055/s-2005-916166.
7
APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.抗凝血酶原酶抵抗是择期髋关节或膝关节置换术后血栓栓塞的一个危险因素——一项前瞻性研究。
Thromb Haemost. 1999 Jan;81(1):18-21.
8
Venous thromboembolism following primary total knee arthroplasty.初次全膝关节置换术后的静脉血栓栓塞症
Int Angiol. 2006 Dec;25(4):343-51.
9
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.海湾地区5个国家静脉血栓栓塞症患者的全球风险概况验证(GRIP VTE)
Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.
10
Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.高危脊柱手术后外科医生关于术后血栓栓塞预防的实践。
Spine (Phila Pa 1976). 2008 Dec 15;33(26):2915-21. doi: 10.1097/BRS.0b013e318190702a.

引用本文的文献

1
Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: a retrospective cohort study in 265 patients.一种用于全膝关节和全髋关节置换的新型血栓预防方案的安全性和有效性:一项对265例患者的回顾性队列研究。
Patient Saf Surg. 2018 Aug 14;12:22. doi: 10.1186/s13037-018-0169-x. eCollection 2018.
2
Incidence of deep venous thrombosis in Chinese patients undergoing arthroscopic knee surgery for cruciate ligament reconstruction.接受关节镜下膝关节十字韧带重建手术的中国患者深静脉血栓形成的发生率。
Knee Surg Sports Traumatol Arthrosc. 2015 Dec;23(12):3540-4. doi: 10.1007/s00167-014-3216-x. Epub 2014 Nov 2.
3
Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
择期髋关节和膝关节置换术以及利伐沙班和依诺肝素血栓预防对伤口愈合的影响。
Eur J Orthop Surg Traumatol. 2013 May;23(4):481-6. doi: 10.1007/s00590-012-0987-y. Epub 2012 Apr 17.
4
Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients.每日一次剂量的低分子量肝素在预防多系统创伤患者静脉血栓栓塞中的效用。
World J Surg. 2007 Jan;31(1):98-104. doi: 10.1007/s00268-006-0304-1.
5
Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--has no clinically relevant interaction with naproxen.利伐沙班(BAY 59-7939)——一种口服的直接Xa因子抑制剂——与萘普生不存在临床相关相互作用。
Br J Clin Pharmacol. 2007 Apr;63(4):469-76. doi: 10.1111/j.1365-2125.2006.02776.x. Epub 2006 Nov 13.